1. Left ventricular cardiac hemangioma in a patient with chronic heart failure
   Hiroyoshi Yamamoto et al, 2018, Journal of Medical Ultrasonics CrossRef
2. Clinical Practice Guideline for the Management of Infantile Hemangiomas
   Daniel P. Krowchuk et al, 2019, Pediatrics CrossRef
3. Tissue and serum mRNA profile of MMPs-2/9 as a potential novel biomarker for the most individual approach in infantile hemangiomas and cancer disease
   Katarzyna Taran et al, 2017, Immunobiology CrossRef
4. Association between hypertension and Epstein-Barr virus reactivation among the population in a high-risk area for nasopharyngeal carcinoma
   Kena Lin et al, 2023, Virus Research CrossRef
5. Refractive Outcome in Preterm Newborns With ROP After Propranolol Treatment. A Retrospective Observational Cohort Study
   Luca Filippi et al, 2019, Frontiers in Pediatrics CrossRef
6. IADVL SIG pediatric dermatology (academy) recommendations on Hemangioma of Infancy (HOI)
   MinuJ Chiramel et al, 2023, Indian Dermatology Online Journal CrossRef
7. The Effect of 0.5% Timolol Maleate on Corneal(Lymph)Angiogenesis in a Murine Suture Model
   Yang Kyung Cho et al, 2018, Journal of Ocular Pharmacology and Therapeutics CrossRef
8. A successful tale of sirolimus treatment in refractory vascular tumors
   Iman Ahmed Ragab et al, 2022, Journal of Pediatric Surgery Case Reports CrossRef
9. Das infantile Hämangiom: Pathogenese und Wirkmechanismus von Propranolol
   Anita Rotter et al, 2017, JDDG: Journal der Deutschen Dermatologischen Gesellschaft CrossRef
10. Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial
    Luca Filippi et al, 2017, BMC Pediatrics CrossRef
11. Importance of Determining Vascular Endothelial Growth Factor Serum Levels in Children with Infantile Hemangioma
    Arnes Rešić et al, 2023, Medicina CrossRef
12. A large-scale retrospective study of the overall survival outcome in nasopharyngeal carcinoma with hypertension in Chinese population
    Pei Yang et al, 2017, Oncotarget CrossRef
13. Evaluation of effect of propranolol on serum vascular endothelial growth factor and tissue inhibitor of metalloproteinase-2 levels in infantile hemangioma
    Anand Pandey et al, 2020, Journal of Indian Association of Pediatric Surgeons CrossRef
14. Infantile hemangioma: pathogenesis and mechanisms of action of propranolol
    Anita Rotter et al, 2017, JDDG: Journal der Deutschen Dermatologischen Gesellschaft CrossRef
15. Can Propranolol Affect Platelet Indices in Infantile Hemangioma?
    Nilgun Eroglu et al, 2023, Journal of Pediatric Hematology/Oncology CrossRef
16. Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes
    Meerim Park et al, 2020, Pediatric Research CrossRef
17. Should all infantile hemangiomas be treated? − Time to learn, unlearn, and relearn
    SanoberBurzin Daruwalla et al, 2022, Indian Journal of Paediatric Dermatology CrossRef